PARP抑制剂调控核糖基化介导卵巢癌CD47表达增强的机制研究
81773754
2017
H3505.抗肿瘤药物药理
丁玲
面上项目
副教授
浙江大学
48万元
核糖基化;STAT3;CD47;卵巢癌;PARP抑制剂
2018-01-01到2021-12-31
- 中英文摘要
- 结题摘要
- 结题报告
- 项目成果
- 项目参与人
查看更多信息请先登录或注册
查看更多信息请先登录或注册
查看更多信息请先登录或注册
| 序号 | 标题 | 类型 | 作者 |
|---|---|---|---|
| 1 | Dihydropyridine Calcium Channel Blockers Suppress the Transcription of PD-L1 by Inhibiting the Activation of STAT1 | 期刊论文 | Pan Xiaohui;Li Run;Guo Hongjie;Zhang Wenxin;Xu Xiaqing;Chen Xi;Ding Ling |
| 2 | Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses | 期刊论文 | Chen Xi;Pan Xiaohui;Zhang Wenxin;Guo Hongjie;Cheng Shuyuan;He Qiaojun;Yang Bo;Ding Ling |
| 3 | Intrinsic and acquired resistance to CDK4/6 inhibitors and potential overcoming strategies | 期刊论文 | Xu Xia-qing;Pan Xiao-hui;Wang Ting-ting;Wang Jian;Yang Bo;He Qiao-jun;Ding Ling |
| 4 | PARP1 Suppresses the Transcription of PD-L1 by Poly(ADP-Ribosyl)ating STAT3 | 期刊论文 | Ding Ling;Chen Xi;Xu Xiaqing;Qian Yuli;Liang Guikai;Yao Fengqi;Yao Zhangting;Wu Honghai;Zhang Jieqiong;He Qiaojun;Yang Bo |
查看更多信息请先登录或注册
